The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line.
暂无分享，去创建一个
T. Ashizawa | A. Iizuka | Ryota Kondou | H. Miyata | T. Sugino | K. Yamaguchi | Mamoru Ito | Y. Akiyama | Y. Nakasu | A. Asai | Y. Kiyohara | K. Mitsuya | C. Nonomura | N. Hayashi